(19)
(11) EP 4 149 529 A1

(12)

(43) Date of publication:
22.03.2023 Bulletin 2023/12

(21) Application number: 21723753.6

(22) Date of filing: 10.05.2021
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
A61P 31/14(2006.01)
A61K 39/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C12N 2770/20034; A61K 39/04; A61K 2039/523; A61K 2039/57; A61P 31/14
(86) International application number:
PCT/EP2021/062333
(87) International publication number:
WO 2021/228768 (18.11.2021 Gazette 2021/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 11.05.2020 US 202063022741 P
11.05.2020 WO PCT/EP2020/063072

(71) Applicant: Vakzine Projekt Management GmbH
30625 Hannover (DE)

(72) Inventors:
  • GRODE, Leander
    38110 Braunschweig (DE)
  • SHALIGRAM, Umesh
    Pune, Maharashtra 411009 (IN)

(74) Representative: Weiss, Wolfgang 
Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB Postfach 860 820
81635 München
81635 München (DE)

   


(54) PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE SYSTEM